Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. Additionally we are shipping PDE7B Proteins (7) and many more products for this protein.
Showing 10 out of 84 products:
Human Polyclonal PDE7B Primary Antibody for EIA, WB - ABIN954068
Kestenbaum, Glazer, Köttgen, Felix, Hwang, Liu, Lohman, Kritchevsky, Hausman, Petersen, Gieger, Ried, Meitinger, Strom, Wichmann, Campbell, Hayward, Rudan, de Boer, Psaty, Rice, Chen, Li, Arking, Boerwinkle, Coresh, Yang, Levy, van Rooij, Dehghan, Rivaden: Common genetic variants associate with serum phosphorus concentration. in Journal of the American Society of Nephrology : JASN 2010
Show all 5 references for ABIN954068
Human Polyclonal PDE7B Primary Antibody for IP, WB - ABIN493316
Finkel, Duc, Fearon, Dang, Tomaselli: Detection and modulation in vivo of helix-loop-helix protein-protein interactions. in The Journal of biological chemistry 1993
Show all 3 references for ABIN493316
Human Polyclonal PDE7B Primary Antibody for IP, WB - ABIN493314
Sasaki, Kotera, Omori: Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. in The Biochemical journal 2002
Show all 3 references for ABIN493314
Human Polyclonal PDE7B Primary Antibody for WB - ABIN2786168
Gardner, Robas, Cawkill, Fidock: Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase. in Biochemical and biophysical research communications 2000
PDE7B polymorphisms were not associated with schizophrenia risk.
higher expression of PDE7B might be a novel unfavorable prognostic indicator in MCL (show FH Antibodies), which possess important clinical significance.
PDE7B mRNA expression is obviously higher in mantle cell lymphoma patients compared with normal controls and significantly correlates with unfavorable cytogenetic characteristics.
The low frequency of this 5' untranslated region variant indicates that it does not explain the higher PDE7B expression in patients with chronic lymphocytic leukemia (CLL) but it has the potential to influence other settings that involve a role for PDE7B.
High PDE7B is associated with chronic lymphocytic leukemia.
Genetic variation in the phosphodiesterase 7B is associated with bioavailability of testosterone enanthate.
As a first exploitation of this unique cohort, we identify three novel candidate dyslexia genes, ZNF280D (show ZNF280D Antibodies) and TCF12 (show TCF12 Antibodies) at 15q21, and PDE7B at 6q23.3, by molecular mapping of the familial translocation with the 15q21 breakpoint.
higher levels than in normal B-cell of PDE7B are found in chronic lymphocytic leukemia
For the first time, it was demonstrated that the deletion of the PDE7B gene or the pharmacological inhibition of PDE7A (show PDE7A Antibodies) and -B had no effect on ovalbumin (show OVA Antibodies)-induced airway inflammation and airway hyperreactivity.
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family.
, cAMP-specific 3',5'-cyclic phosphodiesterase 7B-like
, cyclic nucleotide phosphodiesterase 7b
, cAMP-specific 3',5'-cyclic phosphodiesterase 7B
, high-affinity cAMP-specific 3',5'-cyclic phosphodiesterase
, rolipram-insensitive phosphodiesterase type 7